NeoGenomics

(NASDAQ) NEO

Current Price$8.90

Market Cap$1.15B

Since IPO (2001)+241%

5 Year-79%

1 Year+13%

1 Month+11%

NeoGenomics Financials at a Glance

Market Cap

$1.15B

Revenue (TTM)

$745.97M

Net Income (TTM)

$99.21M

EPS (TTM)

$-0.77

P/E Ratio

-11.46

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$8.90

Volume

63,364

Open

$8.86

Price

$8.90

Volume

63,364

Open

$8.86

Previous Close

$8.90

Daily Range

$8.48 - $8.96

52-Week Range

$4.72 - $13.74

Dividend

$0.00

Beta (Volatility)

1.58 (High)

Price

$8.90

Volume

63,364

Open

$8.86

Previous Close

$8.90

Daily Range

$8.48 - $8.96

52-Week Range

$4.72 - $13.74

NEO News

Group of medical practitioners having a seminar in board room

3 Top Healthcare Stocks to Buy Right Now

Jim CrumlyJul 12, 2020

2 Stocks to Buy and Hold for Decades

Prosper Junior BakinyMay 9, 2020

The Coronavirus Pandemic Will Test Invitae's Telemedicine Ambitions

Maxx ChatskoMay 5, 2020

Here's Why NeoGenomics Is Tumbling Today

Maxx ChatskoApr 30, 2020

Page 1

NEO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeoGenomics

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

2,500

CEO

Anthony P. Zook

Website

www.neogenomics.com

Headquarters

Fort Myers, FL 33912, US

NEO Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

-14%

Net Income Margin

-13%

Return on Equity

-12%

Return on Capital

-8%

Return on Assets

-7%

Earnings Yield

-8.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.15B

Shares Outstanding

130.21M

Volume

63.36K

Avg. Volume

2.14M

Financials (TTM)

Gross Profit

$282.54M

Operating Income

$66.08M

EBITDA

$1.75M

Operating Cash Flow

$5.23M

Capital Expenditure

$27.01M

Free Cash Flow

$21.78M

Cash & ST Invst.

$159.62M

Total Debt

$472.28M

NeoGenomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$186.67M

+11.1%

Gross Profit

$80.86M

+10.4%

Gross Margin

43.32%

N/A

Market Cap

$1.15B

N/A

Market Cap/Employee

$524.40K

N/A

Employees

2,200

N/A

Net Income

$17.11M

+34.0%

EBITDA

$567.00K

+91.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$262.39M

-6.4%

Accounts Receivable

$167.42M

+10.7%

Inventory

$29.84M

+0.2%

Long Term Debt

$403.70M

+0.8%

Short Term Debt

$4.83M

-97.6%

Return on Assets

-7.37%

N/A

Return on Invested Capital

-8.24%

N/A

Free Cash Flow

$13.14M

+56.0%

Operating Cash Flow

$8.14M

+67.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACRSAclaris Therapeutics, Inc.

ACRSAclaris Therapeutics, Inc.$4.78+0.63%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$8.38+8.55%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$9.13+8.56%

TKNOAlpha Teknova, Inc.

TKNOAlpha Teknova, Inc.$3.64-2.67%

SMTISanara MedTech Inc.

SMTISanara MedTech Inc.$19.15-2.40%

QTRXQuanterix Corporation

QTRXQuanterix Corporation$3.29-0.30%

HUMAHumacyte, Inc.

HUMAHumacyte, Inc.$0.98+9.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.59-0.06%

ERNAErnexa Therapeutics

ERNAErnexa Therapeutics$6.04+0.51%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.94+0.05%

Questions About NEO

What is the current price of NeoGenomics?

NeoGenomics is trading at $8.90 per share.

What is the 52-week range for NeoGenomics?

Over the past 52 weeks, NeoGenomics has traded between $4.72 and $13.74.

How much debt does NeoGenomics have?

As of the most recent reporting period, NeoGenomics reported total debt of $408.53M.

How much cash does NeoGenomics have on hand?

NeoGenomics reported $146.14M in cash and cash equivalents in its most recent financial results.

What is NeoGenomics’s dividend yield?

NeoGenomics does not currently have a dividend yield.

NeoGenomics

NeoGenomics Financials at a Glance

NEO News

Why Shares of NeoGenomics Jumped Today

Why Shares of NeoGenomics Jumped 53.9% This Week

3 Top Small-Cap Stocks to Buy Right Now

NeoGenomics Slumps in Q2 but Readies for Second-Half Rebound

3 Top Healthcare Stocks to Buy Right Now

2 Stocks to Buy and Hold for Decades

The Coronavirus Pandemic Will Test Invitae's Telemedicine Ambitions

Here's Why NeoGenomics Is Tumbling Today

NEO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NeoGenomics

NEO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NeoGenomics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NEO

What is the current price of NeoGenomics?

What is the 52-week range for NeoGenomics?

How much debt does NeoGenomics have?

How much cash does NeoGenomics have on hand?

What is NeoGenomics’s dividend yield?

Premium Investing Services